Literature DB >> 18788724

Desferrithiocin analogues and nephrotoxicity.

Raymond J Bergeron1, Jan Wiegand, James S McManis, Neelam Bharti, Shailendra Singh.   

Abstract

The syntheses of a series of 4'-O-alkylated ( S)-4,5-dihydro-2-(2,4-dihydroxyphenyl)-4-methyl-4-thiazole-carboxylic acid and 5'-O-alkylated ( S)-4,5-dihydro-2-(2,5-dihydroxyphenyl)-4-methyl-4-thiazolecarboxylic acid ligands are described. Their partition between octanol and water, log P(app), is determined, along with their iron-clearing efficiency (ICE) in both non-iron-overloaded, bile duct-cannulated rodents and in iron-overloaded primates. The ligand-promoted biliary ferrokinetics in rats are described for each of the chelators. Plots of log P(app) versus ICE in a rodent model for both the 4'-O-alkylated 2,4-dihydroxy and 5'-O-alkylated 2,5-dihydroxy series produced an inverse parabola plot with r(2) values of 0.97 and 0.81, respectively. The plots indicate an optimum log P(app)/ICE relationship. Because of the nature of the data spread in the 4'-O-alkylated 2,4-dihydroxy series, it will be used to help assess the origin of nephrotoxicity in desferrithiocin analogues: is toxicity simply related to lipophilicity, ICE, or a combination of these properties?

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18788724      PMCID: PMC2778308          DOI: 10.1021/jm8003398

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  49 in total

1.  A comparative study of the iron-clearing properties of desferrithiocin analogues with desferrioxamine B in a Cebus monkey model.

Authors:  R J Bergeron; R R Streiff; E A Creary; R D Daniels; W King; G Luchetta; J Wiegand; T Moerker; H H Peter
Journal:  Blood       Date:  1993-04-15       Impact factor: 22.113

2.  Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major.

Authors:  G M Brittenham; P M Griffith; A W Nienhuis; C E McLaren; N S Young; E E Tucker; C J Allen; D E Farrell; J W Harris
Journal:  N Engl J Med       Date:  1994-09-01       Impact factor: 91.245

3.  Evaluation of desferrithiocin and its synthetic analogues as orally effective iron chelators.

Authors:  R J Bergeron; J Wiegand; J B Dionis; M Egli-Karmakka; J Frei; A Huxley-Tencer; H H Peter
Journal:  J Med Chem       Date:  1991-07       Impact factor: 7.446

4.  A comparison of the iron-clearing properties of 1,2-dimethyl-3-hydroxypyrid-4-one, 1,2-diethyl-3-hydroxypyrid-4-one, and deferoxamine.

Authors:  R J Bergeron; R R Streiff; J Wiegand; G Luchetta; E A Creary; H H Peter
Journal:  Blood       Date:  1992-04-01       Impact factor: 22.113

5.  Survival and causes of death in thalassaemia major.

Authors:  M G Zurlo; P De Stefano; C Borgna-Pignatti; A Di Palma; A Piga; C Melevendi; F Di Gregorio; M G Burattini; S Terzoli
Journal:  Lancet       Date:  1989-07-01       Impact factor: 79.321

Review 6.  Desferrioxamine-induced iron excretion in humans.

Authors:  M J Pippard
Journal:  Baillieres Clin Haematol       Date:  1989-04

7.  Synthesis and biological evaluation of naphthyldesferrithiocin iron chelators.

Authors:  R J Bergeron; J Wiegand; M Wollenweber; J S McManis; S E Algee; K Ratliff-Thompson
Journal:  J Med Chem       Date:  1996-04-12       Impact factor: 7.446

Review 8.  Oxygen radicals in ulcerative colitis.

Authors:  C F Babbs
Journal:  Free Radic Biol Med       Date:  1992       Impact factor: 7.376

Review 9.  Free radicals and antioxidants: a personal view.

Authors:  B Halliwell
Journal:  Nutr Rev       Date:  1994-08       Impact factor: 7.110

Review 10.  Long-term therapy with deferiprone.

Authors:  N F Olivieri
Journal:  Acta Haematol       Date:  1996       Impact factor: 2.195

View more
  4 in total

1.  Deferasirox-induced renal impairment in children: an increasing concern for pediatricians.

Authors:  Laurence Dubourg; Céline Laurain; Bruno Ranchin; Corinne Pondarré; Aoumeur Hadj-Aïssa; Dominique Sigaudo-Roussel; Pierre Cochat
Journal:  Pediatr Nephrol       Date:  2012-04-24       Impact factor: 3.714

2.  Substituent effects on desferrithiocin and desferrithiocin analogue iron-clearing and toxicity profiles.

Authors:  Raymond J Bergeron; Jan Wiegand; Neelam Bharti; James S McManis
Journal:  J Med Chem       Date:  2012-08-13       Impact factor: 7.446

3.  Metabolically programmed iron chelators.

Authors:  Raymond J Bergeron; Neelam Bharti; James S McManis; Jan Wiegand
Journal:  Bioorg Med Chem       Date:  2015-06-29       Impact factor: 3.641

4.  Flavylium Salts: A Blooming Core for Bioinspired Ionic Liquid Crystals.

Authors:  Robert Forschner; Jakob Knelles; Korinna Bader; Carsten Müller; Wolfgang Frey; Andreas Köhn; Yann Molard; Frank Giesselmann; Sabine Laschat
Journal:  Chemistry       Date:  2019-09-18       Impact factor: 5.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.